Levorphanol Tartrate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Specgx Llc. The primary component is Levorphanol Tartrate.
| Product ID | 0406-2224_00e76f1f-7c54-4790-82d2-fce3450fdd9c |
| NDC | 0406-2224 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Levorphanol Tartrate |
| Generic Name | Levorphanol Tartrate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-12-13 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA212024 |
| Labeler Name | SpecGx LLC |
| Substance Name | LEVORPHANOL TARTRATE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-12-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA212024 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-12-13 |
| Ingredient | Strength |
|---|---|
| LEVORPHANOL TARTRATE | 2 mg/1 |
| SPL SET ID: | 759c7040-0be0-4d17-be97-e467e423eaa8 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0406-2224 | Levorphanol Tartrate | Levorphanol Tartrate |
| 0527-3236 | Levorphanol Tartrate | Levorphanol Tartrate |
| 0527-3237 | Levorphanol Tartrate | Levorphanol Tartrate |
| 42358-101 | Levorphanol Tartrate | Levorphanol Tartrate |
| 42358-102 | Levorphanol Tartrate | Levorphanol Tartrate |
| 42358-103 | Levorphanol Tartrate | Levorphanol Tartrate |
| 57664-762 | Levorphanol Tartrate | Levorphanol Tartrate |
| 63629-2093 | Levorphanol Tartrate | Levorphanol Tartrate |
| 69543-412 | Levorphanol Tartrate | Levorphanol Tartrate |
| 69543-417 | Levorphanol Tartrate | Levorphanol Tartrate |
| 70954-236 | Levorphanol Tartrate | Levorphanol Tartrate |